| Literature DB >> 30115855 |
Ling-Hong Miao1, Yan Lin2, Xin Huang3, Wen-Jing Pan4, Qun-Lan Zhou5, Bo Liu6,7, Ming-Chun Ren8, Xian-Ping Ge9,10, Liang-Kun Pan11.
Abstract
The Megalobrama amblycephala (M. amblycephala) is one of the most important economic freshwater fish in China. The molecular mechanism under the glucose intolerance responses which affects the growth performance and feed utilization is still confused. miR-34a was reported as a key regulator in the glucose metabolism, but how did the miR-34a exert its function in the metabolism of glucose/insulin in M. amblycephala was still unclear. In this study, we intraperitoneally injected the miR-34a inhibitor (80 nmol/100 g body weight) into M. amblycephala (fed with high starch diet, 45% starch) for 12 h, and then analyzed the gene expression profiling in livers by RNA-seq. The results showed that miR-34a expression in M. amblycephala livers was inhibited by injection of miR-34a inhibitor, and a total of 2212 differentially expressed genes (DEGs) were dysregulated (including 1183 up- and 1029 downregulated DEGs). Function enrichment analysis of DEGs showed that most of them were enriched in the peroxisome proliferator-activated receptor (PPAR), insulin, AMP-activated protein kinase (AMPK) and janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, which were all associated with the glucose/lipid metabolic and biosynthetic processes. In addition, we examined and verified the differential expression levels of some genes involved in AMPK signaling pathway by qRT-PCR. These results demonstrated that the inhibition of miR-34a might regulate glucose metabolism in M. amblycephala through downstream target genes.Entities:
Keywords: Megalobrama amblycephala; RNA-seq; glucose metabolism; inhibition; miR-34a
Mesh:
Substances:
Year: 2018 PMID: 30115855 PMCID: PMC6121310 DOI: 10.3390/ijms19082417
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The relative expression level of miR-34a in livers of fishes treated with high starch diet. All fishes were treated with 80 nmol/100 g body weight miR-34a inhibitors (antagomiR-34a) for 12, 24, and 48 h, combined with high starch diet (45% wheat starch). Relative expression levels of miR-34a was detected using qRT-PCR. *** notes p < 0.001 vs. control.
Summary of the sequencing data from M. amblycephala.
| Sample | Raw Reads | Clean Reads | Clean Q20 (%) | Clean Q30 (%) | Clean GC (%) |
|---|---|---|---|---|---|
| AntagomiR34a-12h | 40,929,414 | 40,359,036 | 97.33 | 92.81 | 46.96 |
| Control-1 | 51,674,516 | 50,991,682 | 97.39 | 92.97 | 46.35 |
| Control-2 | 52,931,508 | 52,218,818 | 97.47 | 93.14 | 47.20 |
Note: AntagomiR34a-12h: miR-34a knocked down for 12 h sample, control-1 and control-2 were high-starch samples.
Overall assembly statistics for the transcriptome of M. amblycephala.
| Item | Value |
|---|---|
| Total number of sequences | 222,411 |
| Total number of genes | 197,425 |
| Total length of sequences (bp) | 151,079,306 |
| Maximum sequence length (bp) | 16,839 |
| Minimum sequence length (bp) | 200 |
| N50 | 1041 |
Statistics of function annotation.
| Annotated Database | Annotated Number | Transcript Ratio (%) |
|---|---|---|
| All_Assembly_Contig | 222,411 | 100 |
| Nr | 82,223 | 36.97 |
| SwissProt | 57,581 | 25.89 |
| KEGG | 71,045 | 31.94 |
| KOG | 45,994 | 20.68 |
| Pfam | 27,677 | 12.44 |
| GO | 25,433 | 11.44 |
| All_anno_contig | 83,587 | 37.58 |
Figure 2Homologous species distribution of the annotated contigs.
Distribution of simple sequence repeat (SSR)s based on the number of repeat units.
| Repeat Numbers | SSR Type | Total | |||||
|---|---|---|---|---|---|---|---|
| Mono- | Di- | Tri- | Tetra- | Penta- | Hexa- | ||
| 5 | 0 | 0 | 3436 | 996 | 154 | 21 | 4607 |
| 6 | 0 | 4847 | 1545 | 710 | 38 | 11 | 7151 |
| 7 | 0 | 2673 | 948 | 75 | 18 | 1 | 3715 |
| 8 | 0 | 1674 | 873 | 93 | 24 | 1 | 2665 |
| 9 | 0 | 1266 | 134 | 60 | 35 | 0 | 1495 |
| 10 | 11,710 | 1138 | 198 | 60 | 22 | 1 | 13,129 |
| 11 | 7843 | 2036 | 129 | 38 | 24 | 0 | 10,070 |
| 12 | 5217 | 1165 | 84 | 27 | 27 | 0 | 6520 |
| ≥13 | 37,415 | 5640 | 172 | 190 | 64 | 1 | 43,482 |
| Total | 62,185 | 20,439 | 7519 | 2249 | 406 | 36 | 92,834 |
| % | 66.99% | 22.02% | 8.10% | 2.42% | 0.44% | 0.04% | |
Figure 3Open reading frame (ORF) length distribution of the annotated contigs (A) and the predicted ORF length distribution of the unannotated contigs (B) in M. amblycephala.
Figure 4Differentially expressed genes in M. amblycephala in response to miR-34a inhibitor treatment. (A) Blue represents upregulated genes and red represents the downregulated genes in antagomiR34a-12h group vs. control group. |log2FC(Fold change)| ≥ 1 and p-value ≤ 0.05; (B) MA plot of all DEGs, the y-axis represents the logarithm of fold change and the x-axis represents the logarithm of read counts. Red color represents DEGs and black color represents non-DEGs.
Figure 5Gene expression patterns of RNA-Seq and qRT-PCR. β-actin was used as an internal control and used for the normalization of the expression level of each gene. Log-fold changes are expressed as the ratio of gene expression. Error bars represent standard error.
Figure 6Gene ontology enrichments of all differentially expressed genes responded to miR-34a inhibitor treatment.
Figure 7Glucose metabolic-related KEGG pathways for differentially expressed genes responded to miR-34a inhibitor treatment.
Figure 8qRT-PCR analysis of some glucose metabolism-related genes involved in AMPK signaling pathway. * p < 0.05; ** p < 0.01. Data not included between the whiskers was plotted as an outlier with black dot.
Figure 9The potential interaction and molecular mechanism of putative genes involved in glucose metabolism process regulated by miR-34a inhibition. Green indicates downregulation, while and red and yellow note upregulation in our study. Gray notes no detection of dysregulation. The blue, red and grey circles include related genes in JAK-STAT1 pathway, AMPK pathway and PPAR pathway, respectively. The green line with an arrow and the green line with a ball stand for positive and negative effect between genes, and the green dot line with an arrow and the green dot line with a ball stand for supposed positive and negative effect between genes.
Formulation and proximate composition of the HSD (%).
| Ingredient | Quantity (g) | Proximate Composition | (% of Dry Matter) |
|---|---|---|---|
| Casein 1 | 20 | Crude protein | 33.32 |
| Gelatin | 5 | Crude lipid | 8.58 |
| Fish meal 2 | 16 | Digestible carbohydrate | 45.25 |
| Wheat starch 3 | 45 | Energy (kJ·g−1) | 18.55 |
| Soybean oil 4 | 7 | Calcium | 1.06 |
| Vitamin additive 5 | 1 | Total phosphorus | 1.32 |
| Mineral additives 5 | 1 | ||
| Carboxymethycellulose | 4 | ||
| Monocalcium phosphate 5 | 1 |
Note: 1 Provided by Provided by Feeer Co., Ltd. (Shanghai, China), protein content 88.7%; 2 Provided by Tongwei Co., Ltd. (Wuxi, China). Protein content 61.2%; 3 Provided by Jinglingta Co., Ltd. (Wuxi, China); 4 Fat acid content of 0.096% C14:0, 11.479% C16:0, 0.105% C16:1, 0.095% C17:0, 4.264% C18:0, 20.132% C18:1, 55.706% C18:2, 7.247% C18:3n3, 0.319% C20:0, 0.246% C20:1 and 0.313% C22:0; 5 Provided by Wuxi Hanove Animal Health Products Co., Ltd. (Wuxi, China). Vitamins premix and mineral premix was as referred to Ren et al. [54].